PAVmed Inc. — Director's Dealing 2022

Feb 24, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PAVmed Inc. (PAVM)
CIK: 0001624326
Period of Report: 2022-02-18

Reporting Person: Aklog Lishan (Director, Chairman and CEO, 10% Owner)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-02-18	Employee stock option (right to buy)	$1.59	A	200000	Acquired	2032-02-18	Common stock (200000)	Direct

Footnotes

F1: The option vests in 12 quarterly installments, with first installment vesting March 31, 2022.